[Federal Register: January 5, 2004 (Volume 69, Number 2)]
[Notices]               
[Page 365]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05ja04-67]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Advisory Board on Radiation and Worker Health, National Institute 
for Occupational Safety and Health

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:
    Name: Advisory Board on Radiation and Worker Health (ABRWH), 
National Institute for Occupational Safety and Health (NIOSH).
    Time and date: 11 a.m.-5 p.m., January 15, 2004.
    Place: The Cincinnati Airport Marriott, 2395 Progress Drive, 
Hebron, Kentucky 41048, telephone (859) 586-0166, fax (859) 586-0266.
    Status: Closed 9 a.m.-5 p.m., January 15, 2004.
    Background: The Advisory Board on Radiation and Worker Health 
(``the Board'') was established under the Energy Employees Occupational 
Illness Compensation Program Act (EEOICPA) of 2000 to advise the 
President, through the Secretary of Health and Human Services (HHS), on 
a variety of policy and technical functions required to implement and 
effectively manage the new compensation program. Key functions of the 
Board include providing advice on the development of probability of 
causation guidelines which have been promulgated by HHS as a final 
rule, advice on methods of dose reconstruction which have also been 
promulgated by HHS as a final rule, evaluation of the scientific 
validity and quality of dose reconstructions conducted by NIOSH for 
qualified cancer claimants, and advice on the addition of classes of 
workers to the Special Exposure Cohort. In December 2000 the President 
delegated responsibility for funding, staffing, and operating the Board 
to HHS, which subsequently delegated this authority to CDC. NIOSH 
implements this responsibility for CDC. The charter was renewed on 
August 3, 2003, and the President has completed the appointment of 
members to the Board to ensure a balanced representation on the Board.
    Purpose: This board is charged with (a) Providing advice to the 
Secretary, HHS, on the development of guidelines under Executive Order 
13179; (b) Providing advice to the Secretary, HHS, on the scientific 
validity and quality of dose reconstruction efforts performed for this 
Program; and (c) Upon request by the Secretary, HHS, advise the 
Secretary on whether there is a class of employees at any Department of 
Energy facility who were exposed to radiation but for whom it is not 
feasible to estimate their radiation dose, and on whether there is 
reasonable likelihood that such radiation doses may have endangered the 
health of members of this class.
    Matters to be Discussed: The meeting will involve a review and 
discussion of the Independent Government Cost Estimate (IGCE) for task 
order contracts and proposals of work for the performance of these task 
order contracts. The Board may revise or accept the IGCE, the task 
orders, and/or some or all of the ABRWH independent dose reconstruction 
review contractor's bids. These contracts will serve to provide 
technical support consultation to assist the ABRWH in fulfilling its 
statutory duty to advise the Secretary, HHS, on the scientific validity 
and quality of dose estimation and reconstruction efforts under the 
EEOICPA. These discussions will include reviews of the technical 
proposals to determine adequacy of the proposed approach and associated 
contract cost estimates. The information being discussed will include 
information of a confidential nature. The IGCEs will include contract 
cost estimates, the disclosure of which would adversely impact the 
Governments negotiating position and strategy in regards to these 
contracts by giving the ABRWH independent dose reconstruction review 
contractor undue advantage in determining the price associated with its 
bids. The meeting will be closed to the public in accordance with 
provisions set forth regarding subject matter considered confidential 
under the terms of 5 U.S.C. 552b(c)(9)(B), 48 CFR 5.401(b)(1) and (4), 
and 48 CFR 7.304(d), and the Determination of the Director of the 
Management Analysis and Services Office, Centers for Disease Control 
and Prevention, pursuant to Pub. L. 92-463. A summary of this meeting 
will be prepared and submitted within 14 days of the close of the 
meeting.
    The agenda is subject to change as priorities dictate.

FOR FURTHER INFORMATION CONTACT: Larry Elliott, Executive Secretary, 
ABRWH, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226, 
telephone (513) 533-6825, fax (513) 533-6826.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

Ronald Ergle,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 03-32247 Filed 12-31-03; 8:45 am]

BILLING CODE 4163-19-P